Opinion|Videos|October 9, 2024

Clinical Utility of the Modified Friedreich Ataxia Rating Scale

Key Takeaways

  • mFARS is designed to assess Friedreich Ataxia progression in clinical trials, focusing on motor function and disease severity.
  • Its complexity and time requirements may limit routine use in everyday clinical practice.
SHOW MORE

Sub Subramony, M.D., discusses how the modified Friedreich Ataxia Rating Scale (mFARS) is valuable for monitoring disease progression in clinical trials and its applicability in everyday clinical practice for assessing patient status.

Video content above is prompted by the following:

The modified Friedreich Ataxia Rating Scale (mFARS) has been developed to monitor FA disease progression in clinical trials. Is mFARS useful in your everyday clinical practice?

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.


Latest CME

Brand Logo

259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo